779 related articles for article (PubMed ID: 25853647)
1. Non-healing foot ulcers in diabetic patients: general and local interfering conditions and management options with advanced wound dressings.
Uccioli L; Izzo V; Meloni M; Vainieri E; Ruotolo V; Giurato L
J Wound Care; 2015 Apr; 24(4 Suppl):35-42. PubMed ID: 25853647
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing.
Lobmann R; Zemlin C; Motzkau M; Reschke K; Lehnert H
J Diabetes Complications; 2006; 20(5):329-35. PubMed ID: 16949521
[TBL] [Abstract][Full Text] [Related]
3. Testing Elevated Protease Activity: Prospective Analysis of 160 Wounds.
Lockmann A; Schill T; Hartmann F; Grönemeyer LL; Holzkamp R; Schön MP; Thoms KM
Adv Skin Wound Care; 2018 Feb; 31(2):82-88. PubMed ID: 29346149
[TBL] [Abstract][Full Text] [Related]
4. Autolytic debridement of a large, necrotic, fully occluded foot ulcer using a hydrocolloid dressing in a diabetic patient.
Cuschieri L; Debosz J; Miiller P; Celis M
Adv Skin Wound Care; 2013 Jul; 26(7):300-4. PubMed ID: 23777879
[TBL] [Abstract][Full Text] [Related]
5. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success.
Saco M; Howe N; Nathoo R; Cherpelis B
Dermatol Online J; 2016 Aug; 22(8):. PubMed ID: 27617934
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of MMP-inhibiting wound dressings in the treatment of chronic wounds: a systematic review.
Dissemond J; Augustin M; Dietlein M; Faust U; Keuthage W; Lobmann R; Münter KC; Strohal R; Stücker M; Traber J; Vanscheidt W; Läuchli S
J Wound Care; 2020 Feb; 29(2):102-118. PubMed ID: 32058850
[TBL] [Abstract][Full Text] [Related]
7. Wound-healing protocols for diabetic foot and pressure ulcers.
Brem H; Jacobs T; Vileikyte L; Weinberger S; Gibber M; Gill K; Tarnovskaya A; Entero H; Boulton AJ
Surg Technol Int; 2003; 11():85-92. PubMed ID: 12931288
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
[TBL] [Abstract][Full Text] [Related]
9. Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer.
Rayment EA; Upton Z; Shooter GK
Br J Dermatol; 2008 May; 158(5):951-61. PubMed ID: 18284390
[TBL] [Abstract][Full Text] [Related]
10. [New therapeutic strategies for the treatment of difficult wounds].
Onesti MG; Bitonti A; Fino P; Ciotti M; Scuderi N
G Chir; 2008 May; 29(5):212-20. PubMed ID: 18507956
[TBL] [Abstract][Full Text] [Related]
11. Wound healing and treatments for people with diabetic foot ulcers.
Jeffcoate WJ; Price P; Harding KG;
Diabetes Metab Res Rev; 2004; 20 Suppl 1():S78-89. PubMed ID: 15150819
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based protocol for diabetic foot ulcers.
Brem H; Sheehan P; Rosenberg HJ; Schneider JS; Boulton AJ
Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):193S-209S; discussion 210S-211S. PubMed ID: 16799388
[TBL] [Abstract][Full Text] [Related]
13. Healing of elderly patients with diabetic foot ulcers, venous stasis ulcers, and pressure ulcers.
Brem H; Tomic-Canic M; Tarnovskaya A; Ehrlich HP; Baskin-Bey E; Gill K; Carasa M; Weinberger S; Entero H; Vladeck B
Surg Technol Int; 2003; 11():161-7. PubMed ID: 12931298
[TBL] [Abstract][Full Text] [Related]
14. Biological wound matrices with native dermis-like collagen efficiently modulate protease activity.
Tati R; Nordin S; Abdillahi SM; Mörgelin M
J Wound Care; 2018 Apr; 27(4):199-209. PubMed ID: 29637827
[TBL] [Abstract][Full Text] [Related]
15. Benefits of sucrose octasulfate (TLC-NOSF) dressings in the treatment of chronic wounds: a systematic review.
Nair H; Venkateshwaran N; Seetharaman S S; Deng W; Uthaipaisanwong A; Galea E
J Wound Care; 2021 Apr; 30(Sup4):S42-S52. PubMed ID: 33856929
[TBL] [Abstract][Full Text] [Related]
16. Defining a new diagnostic assessment parameter for wound care: Elevated protease activity, an indicator of nonhealing, for targeted protease-modulating treatment.
Serena TE; Cullen BM; Bayliff SW; Gibson MC; Carter MJ; Chen L; Yaakov RA; Samies J; Sabo M; DeMarco D; Le N; Galbraith J
Wound Repair Regen; 2016 May; 24(3):589-95. PubMed ID: 27027492
[TBL] [Abstract][Full Text] [Related]
17. Effect of oxidized regenerated cellulose/collagen matrix on proteases in wound exudate of patients with diabetic foot ulcers.
Ulrich D; Smeets R; Unglaub F; Wöltje M; Pallua N
J Wound Ostomy Continence Nurs; 2011; 38(5):522-8. PubMed ID: 21860331
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers.
Jude EB; Apelqvist J; Spraul M; Martini J;
Diabet Med; 2007 Mar; 24(3):280-8. PubMed ID: 17305788
[TBL] [Abstract][Full Text] [Related]
19. Off-loading total contact cast in combination with hydrogel and foam dressing for management of diabetic plantar ulcer of the foot.
Vaseenon T; Thitiboonsuwan S; Cheewawattanachai C; Pimchoo P; Phanphaisarn A
J Med Assoc Thai; 2014 Dec; 97(12):1319-24. PubMed ID: 25764641
[TBL] [Abstract][Full Text] [Related]
20. Clinical management of diabetic ulcers.
Thomas DR
Clin Geriatr Med; 2013 May; 29(2):433-41. PubMed ID: 23571038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
